five largest customers
“10-K Item 1: 'our five largest customers, including CVS Health, accounted for 43 percent of our fiscal 2026 revenue.'”
Updated
The most significant concentration Cardinal Health discloses is five largest customers at 43%, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Cardinal Health’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1: 'our five largest customers, including CVS Health, accounted for 43 percent of our fiscal 2026 revenue.'”
“10-K Item 1: 'Our two largest GPO relationships in terms of revenue are with Vizient, Inc. and Premier, Inc. ... collectively accounted for 29 percent of our revenue in fiscal 2026'”
“10-K Item 1: 'Our largest customer, CVS Health, accounted for 28 percent of our fiscal 2026 revenue.'”
Cardinal Health's disclosed exposures are all customer-side and they nest inside one another. The five largest customers, including CVS Health, accounted for 43 percent of fiscal 2026 revenue. Within that group, CVS Health alone accounted for 28 percent of revenue. Separately, the Vizient and Premier GPO relationships collectively accounted for 29 percent of revenue. Each is a medium-share exposure and each is a dependency in character; the sources do not say how the GPO and top-customer groups overlap, so they should not be added together. The practical meaning is that a distributor operating on thin margins relies on a handful of purchasing relationships for much of its volume. Contract renewals, pricing resets, a change in a GPO's sourcing strategy, or a shift in a large pharmacy customer's own supply arrangements could alter revenue and profitability without any change in end-market demand. Netted together, the CVS Health relationship is the single idiosyncratic item most likely to move the verdict, while the GPO channels add a structural layer of purchasing-power concentration. All of it is clearly disclosed in the 10-K.
For the engine’s reasoning on CAH’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| COR | Cencora, Inc. | 1 | 1 | 1 | 3 |
| CAH● | Cardinal Health, Inc. | 0 | 3 | 0 | 3 |
| HSIC | Henry Schein, Inc. | 0 | 0 | 0 | 0 |
| MCK | McKesson Corporation | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.